[go: up one dir, main page]

AR076576A1 - Procedimiento para estabilizar un suplemento dietetico para facilitar la salud de las articulaciones en seres humanos - Google Patents

Procedimiento para estabilizar un suplemento dietetico para facilitar la salud de las articulaciones en seres humanos

Info

Publication number
AR076576A1
AR076576A1 ARP100101649A ARP100101649A AR076576A1 AR 076576 A1 AR076576 A1 AR 076576A1 AR P100101649 A ARP100101649 A AR P100101649A AR P100101649 A ARP100101649 A AR P100101649A AR 076576 A1 AR076576 A1 AR 076576A1
Authority
AR
Argentina
Prior art keywords
granulation
composition
articulations
stabilize
health
Prior art date
Application number
ARP100101649A
Other languages
English (en)
Inventor
Denise Lowe Walters
Scott William Poxon
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of AR076576A1 publication Critical patent/AR076576A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Reivindicacion 1: Un procedimiento para fabricar una composicion caracterizado porque comprende glucosamina y calcio que comprende las etapas de (a) proporcionar una primera composicion de granulacion que comprende glucosamina, un primer disgregante y un primer aglutinante, y (b) proporcionar una segunda composicion de granulacion que comprende calcio, un segundo disgregante y un segundo aglutinante; y mezclar la primera granulacion y la segunda granulacion, en donde la composicion tiene una estabilidad de almacenamiento potenciada y/o mejorada. Reivindicacion 3: Un procedimiento para fabricar una composicion caracterizado porque comprende glucosamina y al menos una vitamina o al menos un mineral que comprende: (a) proporcionar una primera composicion de granulacion que comprende glucosamina, un primer disgregante y un primer aglutinante, en donde el pH de la primera granulacion no es mayor que 7 y (b) proporcionar una segunda composicion de granulacion que comprende al menos una vitamina, mineral o ingrediente activo, un segundo disgregante y un segundo aglutinante; y mezclar la primera granulacion y la segunda granulacion, en donde la composicion tiene una estabilidad de almacenamiento potenciada y/o mejorada.
ARP100101649A 2009-05-13 2010-05-12 Procedimiento para estabilizar un suplemento dietetico para facilitar la salud de las articulaciones en seres humanos AR076576A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17788809P 2009-05-13 2009-05-13

Publications (1)

Publication Number Publication Date
AR076576A1 true AR076576A1 (es) 2011-06-22

Family

ID=42635064

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100101649A AR076576A1 (es) 2009-05-13 2010-05-12 Procedimiento para estabilizar un suplemento dietetico para facilitar la salud de las articulaciones en seres humanos

Country Status (9)

Country Link
US (1) US9592202B2 (es)
EP (1) EP2429500B1 (es)
JP (1) JP5689458B2 (es)
AR (1) AR076576A1 (es)
CA (1) CA2758812C (es)
DK (1) DK2429500T3 (es)
ES (1) ES2534312T3 (es)
TW (1) TW201043640A (es)
WO (1) WO2010141191A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5740633B2 (ja) * 2011-06-03 2015-06-24 株式会社東洋新薬 錠剤の製造方法及び錠剤
EP3176222A1 (en) * 2015-12-01 2017-06-07 Omya International AG Method for the production of granules comprising surface-reacted calcium carbonate
JP7334025B2 (ja) * 2017-06-30 2023-08-28 小林製薬株式会社 グルコサミンがカルシウム化合物で被覆されている経口組成物
SG11202006601VA (en) 2018-01-12 2020-08-28 Metimedi Pharmaceuticals Co Ltd Methods of treating chronic inflammatory diseases
BE1029004B1 (nl) * 2021-01-11 2022-08-16 Kori Gcv Nieuw farmaceutische formuleringen, op basis van eenvoudige metabolieten, te gebruiken bij degeneratieve aandoeningen van het zenuwstelsel, bij virale infecties en bij tumorale aandoeningen

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2410417A (en) * 1944-03-04 1946-11-05 Lever Brothers Ltd Vitamin and mineral dietary supplement and method of making
DE1792346C3 (de) 1968-08-22 1980-10-23 Rotta Research Laboratorium S.P.A., San Fruttuoso Di Monza, Mailand (Italien) Pharmazeutisches Präparat für die Behandlung von degenerativen Gelenkerkrankungen
IT1044707B (it) * 1968-10-26 1980-04-21 Rotta Research Lab Procedimento per la preparazione di sali di glucosanina e preparati farmaceutici comprendenti detti sali di glucosamina come agenti attivi
IT1148050B (it) * 1981-04-30 1986-11-26 Rotta Research Lab Composto stabile della glucosamina solfato procedimento per la sua preparazione e composizioni farmaceutiche contenenti tale composto
US4582709A (en) * 1985-02-08 1986-04-15 Warner-Lambert Company Chewable mineral supplement
DE3532081A1 (de) 1985-09-09 1987-03-12 Orion Yhtymae Oy Mischsalze von glucosaminsulfat und verfahren zu ihrer herstellung
US4786510A (en) * 1987-07-02 1988-11-22 The Procter & Gamble Company Calcium-iron mineral supplements
CA2035841C (en) 1990-02-22 1996-02-13 Harry B. Demopoulos Storage-stable glucosamine sulphate oral dosage forms and methods for their manufacture
US5364845C1 (en) * 1993-03-31 2002-09-10 Nutramax Lab Inc Glusosamine chondroitin and manganese composition for the protection and repair of connective tissue
US6492349B1 (en) 1993-03-31 2002-12-10 Nutramax Laboratories, Inc. Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue
GB9414045D0 (en) * 1994-07-12 1994-08-31 Berwind Pharma Service Moisture barrier film coating composition, method, and coated form
US5840715A (en) * 1995-12-11 1998-11-24 Inholtra Investment Holdings & Trading, N.V. Dietary regimen of nutritional supplements for relief of symptoms of arthritis
US5916565A (en) 1996-03-08 1999-06-29 In Clover, Inc. Product and method for treating joint disorders in vertebrates
US5922692A (en) 1998-03-11 1999-07-13 Marino; Richard P. Concentration of glycosaminoglycans and precursors thereto in food products
JP2001064159A (ja) 1999-08-25 2001-03-13 Shionogi & Co Ltd 複合顆粒剤
US6358526B1 (en) * 2000-08-16 2002-03-19 Rexall Sundown Method of making tablets and tablet compositions produced therefrom
KR101389061B1 (ko) * 2004-03-29 2014-04-28 와이어쓰 엘엘씨 종합비타민 및 무기물 영양 보충제
US8859011B2 (en) * 2006-05-12 2014-10-14 Particle Dynamics International, Llc Calcium compositions
CA2587805C (en) * 2007-04-25 2014-02-18 The Procter & Gamble Company Improved vitamin d content uniformity in pharmaceutical dosage forms
WO2008136016A1 (en) * 2007-05-08 2008-11-13 Medreich Limited A stable controlled release oral solid dosage form composition and a process thereof
JO3272B1 (ar) * 2007-07-19 2018-09-16 Takeda Pharmaceuticals Co مستحضر صلب يشمل ألوجليبتين وميتفورمين هيدروكلوريد

Also Published As

Publication number Publication date
EP2429500A1 (en) 2012-03-21
CA2758812C (en) 2015-03-31
JP5689458B2 (ja) 2015-03-25
TW201043640A (en) 2010-12-16
CA2758812A1 (en) 2010-12-09
WO2010141191A1 (en) 2010-12-09
US9592202B2 (en) 2017-03-14
DK2429500T3 (en) 2015-03-09
JP2012526835A (ja) 2012-11-01
EP2429500B1 (en) 2015-01-14
ES2534312T3 (es) 2015-04-21
US20100291240A1 (en) 2010-11-18

Similar Documents

Publication Publication Date Title
UY30905A1 (es) Composiciones para mejorar la absorcion gastrointestinal de nutrientes y farmacos
BR112014031914A2 (pt) cápsula de estradiol solúvel para inserção vaginal
CL2010001260A1 (es) Composicion farmaceutica que comprende una sal de estroncio y vitamina d y una ciclodextrina, donde la relacion masica entre la cantidad de vitamina d y la cantidad de ciclodextrina esta comprendida entre 1/40 y 1/800, util para tratar o prevenir osteoporosis.
UA109650C2 (xx) Біс-арилзв'язані арилтриазолони та їх застосування
WO2010111640A3 (en) Anti-influenza formulations and methods
MX2012004869A (es) Formulaciones espesantes estables.
EP2045253A4 (en) alpha-amino acid derivative and pharmaceutical agent containing it as an active ingredient
BR112012005044A2 (pt) composições que compreendem tramadol e celecoxib no tratamento de dor.
DOP2007000043A (es) Derivados de cromanol sustituidos y su uso
AR076576A1 (es) Procedimiento para estabilizar un suplemento dietetico para facilitar la salud de las articulaciones en seres humanos
BR112012007798A2 (pt) microcápsulas estáveis e composição para aplicação tópica e método para a preparação de microcápsulas
CL2013002700A1 (es) Cápsula suave ingerible que contiene inositol y excipientes, o inositol, excipientes y al menos un principio activo adicional, tal como ácido fólico, polifenoles de cocoa, genisteína, l-arginina, vitamina e, selenio, n-acetilcisteína y melatonina; útil para el tratamiento del ovario poliquístico, resistencia a la insulina y otros
TR201004464A2 (tr) Kemik erimesi için formülasyon.
BR112012021445A2 (pt) formulação farmacêutica ou neutracêutica.
UY31662A1 (es) Composiciones de tabletas de ranitidina de desintegracion oral y sus metodos de elaboracion.
UY29416A1 (es) Derivados de ácido pirimidincarboxílico y su uso
ATE458748T1 (de) Proteinbindende methotrexat-derivate und diese enthaltende arzneimittel
CO6450623A2 (es) Parasiticidas sanguineos
BR112012030485A2 (pt) composição para prevenção ou tratamento de osteoporose e processo de fabricação para a mesma
BRPI0700133A (pt) composição farmacêutica compreendendo tramadol e cetoprofeno em combinação
DOP2006000208A (es) Suplementos nutricionales con fitosterol
HK1199841A1 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
ATE452120T1 (de) Fettsäure-benzenediol-derivate sowie herstellungs-und verwendungsverfahren dafür
TR200909785A1 (tr) Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar.
MX2009005329A (es) Composiciones farmaceuticas anticonvulsivas.

Legal Events

Date Code Title Description
FC Refusal